EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan
Year: 2013
Type: article
Source: Targeted Oncology
Authors: Fotios Loupakis, Chiara Cremolini, Anna Fioravanti, Paola Orlandi, Lisa Salvatore, Gianluca Masi, Marta Schirripa, Teresa Di Desidero, Carlotta Antoniotti, Bastianina Canu, Pinuccia Faviana, Elisa Sensi, Cristiana Lupi, Gabriella Fontanini, Fulvio Basolo, Antonello Di Paolo, Romano Danesi, Alfredo Falcone, Guido Bocci
Institutions: University of Pisa, Azienda Ospedaliera Universitaria Pisana
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: EGFR ligands, pharmacodynamic biomarkers, metastatic colorectal cancer, cetuximab, irinotecan, amphiregulin, epidermal growth factor, transforming growth factor-alpha, heparin-binding EGF, KRAS mutation, BRAF mutation, anti-EGFR resistance, plasma biomarkers, progression-free survival, overall survival
Open Access status: closed
OpenAlex ID: W1984952201
